Powered by HealthTechMovers.com
We added 2 stocks to our Healthcare & Biotech Stock Watchlist today because they are receiving Bullish Sentiment from investors and financial bloggers.
In addition, they are generating positive media buzz and/or have insider trading signals which came to our attention. This list below is subject to change on a daily basis, so please be sure you subscribe to our email newsletter.
Natera, NTRA
Summary: Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
- Last Price: 61.53
- Price Change: -0.37, -0.60%
- Yearly Gain: -43.02%
- Market Cap: 5.82B
- P/E Ratio: -13.531
Here are 3rd party ratings for NTRA:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Bottom 27% (185 out of 254)
What is the sentiment on the street regarding Natera ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: Medium
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: Very Negative
If you are interested in NTRA or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on NTRA before you decide to make any investment.
Click here for chart >>
NeoGenomics, NEO
Summary: NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
- Last Price: 20.25
- Price Change: 0.1, 0.50%
- Yearly Gain: -62.18%
- Market Cap: 2.49B
- P/E Ratio: 54.666
Here are 3rd party ratings for NEO:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Bottom 38% (157 out of 254)
What is the sentiment on the street regarding NeoGenomics ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Negative
- Blogger Consensus: Bearish
- Media Buzz: Medium
- Insider Signal: Negative
- Investor Sentiment: Very Negative
- Hedge Fund signal: Very Negative
If you are interested in NEO or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on NEO before you decide to make any investment.
Click here for chart >>
Thanks for reading!